“…CDR1as is upregulated in numerous cancers, where it can sponge miR-7 and stimulate the expression of the downstream targeted genes, such as E2F3, EGFR, IGF-1R, CCNE1, PIK3CD, RAF1, PTEN, and KLF4. Accordingly, CDR1as was found to promote tumor proliferation in nasopharyngeal carcinoma, colorectal cancer, non-small-cell lung cancer, osteosarcoma, laryngeal squamous cell carcinoma, gastric cancer and esophageal squamous cell carcinoma, respectively (Tang et al, 2017;Li R. C. et al, 2018;Pan et al, 2018;Xu et al, 2018;Zhang J. et al, 2018;Zhang X. et al, 2018;Huang et al, 2019;Zhong et al, 2019;Yang et al, 2020). These studies demonstrated CDR1as-miR-641 Jiang et al, 2018;Li D. et al, 2020 Gastric cancer Upregulated Proliferation Migration Chemoresistance…”